AnalystsStan BerenshteynStan Berenshteyn's Stock Forecasts
AnalystsStan Berenshteyn
Sectors:
Industries:
Analyst Ranking
Bottom 9%
#4484 out of 4868 analysts
Average Return
-5.91%
Win Rate
52%16 out of 31
Risk vs Reward
Poor
Good
Stan Berenshteyn's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Accolade IncACCD | +53.41% | $13.80 | $6.43 | 2022-04-10 - 2022-05-02 | Strong Sell |
Omnicell IncOMCL | +51.58% | $62.87 | $30.44 | 2023-07-19 - 2023-11-03 | Strong Sell |
Healthequity IncHQY | +45.46% | $69.33 | $100.85 | 2023-12-05 - 2024-12-05 | Strong Buy |
Doximity IncDOCS | +35.25% | $26.47 | $35.80 | 2022-10-30 - 2023-05-01 | Strong Buy |
Omnicell IncOMCL | +33.22% | $45.58 | $30.44 | 2023-09-25 - 2023-11-03 | Strong Sell |
Stan Berenshteyn Analyst Color
Get additional color on Stan Berenshteyn's coverage of popular stocks
Stan Berenshteyn's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Goodrx Holdings IncGDRX | 8 | Strong Buy | $7.00 | +51.19% | Maintains | 2 days ago |
Omnicell IncOMCL | 13 | Hold | $38.00 | +21.56% | Maintains | 14 days ago |
Healthequity IncHQY | 9 | Strong Buy | $125.00 | +45.82% | Maintains | 2 months ago |
Doximity IncDOCS | 10 | Hold | $55.00 | -3.31% | Maintains | 3 months ago |
Health Catalyst IncHCAT | 5 | Strong Buy | $10.00 | +153.16% | Maintains | 3 months ago |
American Well CorpAMWL | 3 | Strong Buy | $15.00 | +104.64% | Upgrades | 4 months ago |
Veeva Systems IncVEEV | 5 | Strong Buy | $285.00 | +21.96% | Maintains | 5 months ago |
Accolade IncACCD | 10 | Hold | $6.00 | -14.53% | Maintains | 7 months ago |
Teladoc Health IncTDOC | 2 | Hold | $23.00 | N/A | Maintains | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.